BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7537556)

  • 1. Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2.
    Ishihara M
    Glycobiology; 1994 Dec; 4(6):817-24. PubMed ID: 7537556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural features in heparin which modulate specific biological activities mediated by basic fibroblast growth factor.
    Ishihara M; Shaklee PN; Yang Z; Liang W; Wei Z; Stack RJ; Holme K
    Glycobiology; 1994 Aug; 4(4):451-8. PubMed ID: 7827407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4.
    Guimond S; Maccarana M; Olwin BB; Lindahl U; Rapraeger AC
    J Biol Chem; 1993 Nov; 268(32):23906-14. PubMed ID: 7693696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of 6-O-sulfate groups of glucosamine residues in heparin for activation of FGF-1 and FGF-2.
    Ishihara M; Takano R; Kanda T; Hayashi K; Hara S; Kikuchi H; Yoshida K
    J Biochem; 1995 Dec; 118(6):1255-60. PubMed ID: 8720143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-dependent fibroblast growth factor activities: effects of defined heparin oligosaccharides.
    Zhou FY; Kan M; Owens RT; McKeehan WL; Thompson JA; Linhardt RJ; Höök M
    Eur J Cell Biol; 1997 May; 73(1):71-80. PubMed ID: 9174673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes.
    Ostrovsky O; Berman B; Gallagher J; Mulloy B; Fernig DG; Delehedde M; Ron D
    J Biol Chem; 2002 Jan; 277(4):2444-53. PubMed ID: 11714710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of affinity-fractionated, heparin-derived oligosaccharides and their effects on selected biological activities mediated by basic fibroblast growth factor.
    Ishihara M; Tyrrell DJ; Stauber GB; Brown S; Cousens LS; Stack RJ
    J Biol Chem; 1993 Mar; 268(7):4675-83. PubMed ID: 8444841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs.
    Ye S; Luo Y; Lu W; Jones RB; Linhardt RJ; Capila I; Toida T; Kan M; Pelletier H; McKeehan WL
    Biochemistry; 2001 Dec; 40(48):14429-39. PubMed ID: 11724555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides.
    Ornitz DM; Herr AB; Nilsson M; Westman J; Svahn CM; Waksman G
    Science; 1995 Apr; 268(5209):432-6. PubMed ID: 7536345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is dependent on specific structural features: differential requirements for the modulation of FGF-1 and FGF-2.
    Pye DA; Vivès RR; Hyde P; Gallagher JT
    Glycobiology; 2000 Nov; 10(11):1183-92. PubMed ID: 11087710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of 2-O-sulfate groups of uronate residues in heparin for activation of FGF-1 and FGF-2.
    Ishihara M; Kariya Y; Kikuchi H; Minamisawa T; Yoshida K
    J Biochem; 1997 Feb; 121(2):345-9. PubMed ID: 9089410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-derived oligosaccharides: affinity for acidic fibroblast growth factor and effect on its growth-promoting activity for human endothelial cells.
    Bârzu T; Lormeau JC; Petitou M; Michelson S; Choay J
    J Cell Physiol; 1989 Sep; 140(3):538-48. PubMed ID: 2550475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural specificity of heparin binding in the fibroblast growth factor family of proteins.
    Raman R; Venkataraman G; Ernst S; Sasisekharan V; Sasisekharan R
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2357-62. PubMed ID: 12604799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligomerization reduces heparin affinity but enhances receptor binding of fibroblast growth factor 2.
    Safran M; Eisenstein M; Aviezer D; Yayon A
    Biochem J; 2000 Jan; 345 Pt 1(Pt 1):107-13. PubMed ID: 10600645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts.
    Delehedde M; Lyon M; Gallagher JT; Rudland PS; Fernig DG
    Biochem J; 2002 Aug; 366(Pt 1):235-44. PubMed ID: 12000311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural features in heparin that interact with VEGF165 and modulate its biological activity.
    Ono K; Hattori H; Takeshita S; Kurita A; Ishihara M
    Glycobiology; 1999 Jul; 9(7):705-11. PubMed ID: 10362840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the murine BEK fibroblast growth factor (FGF) receptor: activation by three members of the FGF family and requirement for heparin.
    Mansukhani A; Dell'Era P; Moscatelli D; Kornbluth S; Hanafusa H; Basilico C
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3305-9. PubMed ID: 1373495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorospectrometric analysis of heparin interaction with fibroblast growth factors.
    Li LY; Seddon AP
    Growth Factors; 1994; 11(1):1-7. PubMed ID: 7530465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor.
    Maccarana M; Casu B; Lindahl U
    J Biol Chem; 1993 Nov; 268(32):23898-905. PubMed ID: 8226930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and function of fibroblast growth factor.
    Gambarini AG; Miranda MT; Viviani W; Oyama Júnior S; Kiyota S; Toma IN
    Braz J Med Biol Res; 1996 Jul; 29(7):835-9. PubMed ID: 9070372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.